CompletedPhase 2NCT00002547

Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome

Studying Acute erythroid leukemia

Last synced from ClinicalTrials.gov May 18, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Barbara Ann Karmanos Cancer Institute
Principal Investigator: Esteban Abella, MD, MD
Barbara Ann Karmanos Cancer Institute
Intervention: busulfan(drug)
Enrollment: 280 enrolled
Eligibility: 60 years · All sexes
Timeline: 1987 – 2003

Study locations (1)

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00002547 on ClinicalTrials.gov

Other trials for Acute erythroid leukemia

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGPHASE2NCT00658814
Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
National Cancer Institute (NCI)

See all trials for Acute erythroid leukemia →

← Back to all trials